/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2015-04-27 16:48:322016-09-21 15:18:33iSTAR Medical Appoints Medical Device Executive Michel Lussier as Chairman of its Board of Directors
Isnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo™ glaucoma drainage device.
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2014-10-30 16:45:172016-09-21 15:18:48iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial
Isnes, Belgium (July 16, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.
https://www.istarmed.com/wp-content/uploads/2014/07/news_michel.png307920admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2014-07-16 16:41:352016-09-21 13:57:30iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer
Isnes, Belgium (April 29, 2014) – iSTAR Medical SA (iSTAR), a medical device company specializing in ophthalmic implants, announced today the addition of Prof. Michael Belkin, MD, to its Scientific Advisory Board (SAB). Prof. Belkin is professor emeritus of Ophthalmology at Tel-Aviv University where he is the director of the Ophthalmic Technologies Laboratory at the […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2014-04-29 16:38:142016-09-27 11:00:37iSTAR Medical Adds Glaucoma Pioneer Prof. Michael Belkin, MD, to Scientific Advisory Board
Proceeds to Support Advancement of STARfloTM Glaucoma Implant Isnes, Belgium (November 21, 2013) – iSTAR Medical SA, a privately held ophthalmic device company and first spinout of Healionics Corporation, today announced it has raised EUR 4.0 million from institutional investors in a Series A financing. The financing was coled by Capricorn Health-Tech Fund NV (CHF) […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2013-11-21 16:34:342016-09-27 11:02:01iSTAR Medical Raises EUR 4 million in Series A Financing